NEW YORK, NY — As the world enters the mid-point of Breast Cancer Awareness Month, a global movement is preparing to shift the narrative from "early detection" to the stark, often overlooked reality of Stage 4 disease. On October 13, 2026, more than 325 landmarks across 50 U.S. states and 20 countries will be bathed in teal, green, and pink light. This coordinated display marks the centerpiece of the #LightUpMBC campaign, an initiative by METAvivor Research and Support designed to honor those lost to metastatic breast cancer (MBC) and to fund the research necessary to save those currently living with it.
While the "pink ribbon" has become a universal symbol for breast cancer, the #LightUpMBC campaign seeks to highlight the specific colors of metastatic awareness: teal for healing and spirituality, green for hope and renewal, and pink for the origins of the disease. As the sun sets on October 13, iconic structures including One World Trade Center in New York, the Willis Tower in Chicago, and the Mactan-Cebu Airport in the Philippines will serve as luminous reminders that for those with Stage 4 cancer, the battle is never truly "over."
Main Facts: The Scope of the #LightUpMBC Campaign
The 2026 iteration of #LightUpMBC represents the largest coordinated awareness effort in the history of metastatic breast cancer advocacy. Spanning 195 cities globally, the event is not merely a visual tribute but a strategic fundraising vehicle. To date, the campaign has raised over $2.7 million, with 100% of net proceeds directed toward scientific grants for Stage 4 research.
The campaign culminates in "#LightUpMBC Live," a virtual broadcast scheduled for 8 p.m. ET / 5 p.m. PT on October 13. Hosted by Tami Eagle Bowling, a prominent advocate living with MBC for 11 years, and Broadway star Kara Lindsay, the program blends patient testimonials with scientific discourse and high-caliber musical performances. By leveraging both physical landmarks and digital platforms, METAvivor aims to pierce the "pink noise" of October and focus public attention on the only form of breast cancer that is currently terminal.
Chronology: From a Single Bridge to a Global Phenomenon
The origins of #LightUpMBC are rooted in a personal promise and a singular act of advocacy. In 2017, the movement began when the Memorial Bridge in Portsmouth, New Hampshire, became the first landmark to illuminate specifically for metastatic breast cancer. The spark for this initiative was Jessica Moore, a young woman diagnosed with MBC who passed away at the age of 36.
Jessica’s wish was simple: she wanted to see one local landmark light up to acknowledge the reality of her disease. Following her death, her best friend, Laura Inahara, took up the mantle. What began as a local tribute in New Hampshire quickly resonated with the MBC community—a group that frequently feels marginalized by mainstream breast cancer campaigns that emphasize "survivorship" and "cures" that do not yet exist for Stage 4 patients.
By 2019, the campaign had expanded to several dozen landmarks. By 2022, it had crossed international borders. Now, in 2026, the movement has achieved a truly global footprint. The growth of #LightUpMBC mirrors the rising influence of METAvivor, which was founded in 2009 by a small group of patients who were frustrated that only a tiny fraction of breast cancer research funding (estimated at 2-5%) was being directed toward the metastatic stage, despite it being the cause of nearly all breast cancer deaths.
Supporting Data: The Medical and Statistical Reality of MBC
To understand the urgency behind the #LightUpMBC campaign, one must look at the epidemiological data surrounding the disease. Metastatic breast cancer occurs when cancer cells break away from the primary tumor in the breast and travel through the lymphatic system or bloodstream to other parts of the body. The most common sites of metastasis are the bones, liver, lungs, and brain.
The Mortality Gap
According to data from the National Cancer Institute’s SEER program, an estimated 42,670 people in the United States are expected to die from breast cancer in 2026. This equates to approximately 117 deaths every day. Despite advances in screening and early-stage treatment, these mortality figures have remained stubbornly high, largely because once breast cancer metastasizes, there is no known cure.
The Myth of the "All Clear"
A significant portion of the MBC population consists of "de novo" patients—those diagnosed at Stage 4 from the very beginning. However, many others are "recurrence" patients who were previously treated for early-stage cancer and told they were "cancer-free," only for the disease to return years or even decades later. Supporting data suggests that roughly 30% of women diagnosed with early-stage breast cancer will eventually progress to metastatic disease.
Research Funding Disparities
Historically, the vast majority of breast cancer fundraising has been allocated to awareness, early detection, and primary prevention. While these are vital components of public health, they do little for the hundreds of thousands of people currently living with Stage 4 disease. METAvivor remains one of the only organizations that exclusively funds Stage 4 research, utilizing a rigorous peer-review process that includes both oncology scientists and patient advocates to ensure that the research has the highest potential for clinical impact.
Official Responses: Voices from the Frontlines
The leadership of METAvivor and the founders of the campaign emphasize that while the lights are beautiful, the mission is strictly utilitarian: survival.
Dr. Kelly Shanahan, METAvivor Board President and a physician living with MBC since 2013, highlighted the transformative power of research. "When I was diagnosed… I certainly didn’t think I’d still be here 13 years later," Dr. Shanahan stated. "My hope and the hope of so many others lies in research. METAvivor-funded research is increasingly important these days. #LightUpMBC is the biggest contributor to this research and is also a way to bring us together as a community."
Laura Inahara, the founder of the campaign, reflects on the legacy of her friend Jessica Moore. "Jessica hoped to illuminate one local landmark. Today, her legacy helps families around the world shine a light for the people they love," Inahara said. She noted that the campaign has moved beyond mere visibility, raising over $2.7 million to date. "It teaches patients with MBC how to advocate for themselves and has now raised critical funds for MBC research."
The entertainment community has also rallied behind the cause. The 2026 live stream features a roster of acclaimed talent, including two-time Tony Award winner Victoria Clark and Tony Award nominee Dorian Harewood. Their participation underscores the campaign’s success in moving MBC advocacy into the cultural mainstream.
Implications: Redefining "Awareness" and the Future of Oncology
The #LightUpMBC campaign carries profound implications for how society views terminal illness and how the medical community approaches cancer treatment.
Shifting from "Terminal" to "Chronic"
The ultimate goal of METAvivor’s research funding is to transition MBC from a terminal diagnosis to a manageable chronic condition. Much like HIV/AIDS was transformed from a death sentence in the 1980s to a survivable condition through targeted research and drug "cocktails," advocates believe that with enough funding, MBC patients can live long, high-quality lives through a succession of therapies.
The Critique of "Pinkwashing"
The campaign serves as a structural critique of "pinkwashing"—the corporate practice of using pink ribbons to sell products without contributing meaningfully to the search for a cure. By using teal and green alongside pink, #LightUpMBC forces a conversation about the limitations of current medical technology. It challenges the "survivor" narrative that can often leave Stage 4 patients feeling isolated or blamed for their "failure" to beat the disease.
Global Advocacy Networks
The inclusion of landmarks in the Philippines, Scotland, and Canada signals the emergence of a global advocacy network. As MBC patients around the world connect via social media and campaigns like #LightUpMBC, they are creating a unified voting and donor bloc that can influence international research priorities.
The Role of Patient-Led Science
METAvivor’s model of including patient advocates in the grant review process is a significant shift in the scientific landscape. It ensures that research is not just theoretically sound but practically relevant to the quality of life and longevity of the patients themselves. This "patient-centric" approach is increasingly being adopted by other disease-specific nonprofits.
Conclusion: A Call to Action
As October 13 approaches, the public is encouraged to do more than just watch the lights. METAvivor is calling for active participation through social media and direct donations. Supporters are invited to photograph participating landmarks and share them using the hashtags #LightUpMBC and #METAvivor, tagging @LightUpMBC to amplify the message.
The 2026 #LightUpMBC campaign is a testament to the power of a single wish evolved into a global mandate. In a month often dominated by celebratory messages of "beating" cancer, the teal, green, and pink lights of October 13 offer a more nuanced, urgent, and ultimately hopeful reality: that while there is not yet a cure, there is a path forward through science, and a community that refuses to be left in the dark.
For more information on participating landmarks, to view the live stream, or to contribute to metastatic breast cancer research, visit www.lightupmbc.org.
About METAvivor:
METAvivor Research and Support Inc. is a 501(c)(3) nonprofit organization dedicated to the specific fight against Stage 4 metastatic breast cancer. It is the only organization in the United States that exclusively funds MBC research, ensuring that every dollar raised goes toward projects aimed at extending the lives of those with metastatic disease.
Press Contact:
Tami Eagle Bowling
[email protected]
About the Author
